Medical Disorders
Resources
Basic InformationLookupsLatest News
Your Gas Stove Might Make You (and the Planet) SickShorter Life Spans for Elderly Living Downwind of Fracking Sites: StudyIn a First, a Robot Performs Laparoscopic Surgery on Pig Without Human Help2 Rheumatoid Arthritis Drugs Tied to Lower Risk of Parkinson'sBeyond Antibodies: Vaccines Teach Your Immune T-Cells to Fight COVID Long TermRehab or Steroid Shots: What's Best for Arthritic Knees?Pre-Op Treatment May Be Advance Against Deadly Liver CancersMonths After Moderna Booster, Antibodies Decline Faster With OmicronHospital Defends Decision to Deny Heart Transplant to Unvaccinated ManScientists Regrow Frog's Lost Leg: Could Human Amputees Someday Do the Same?Almost 1 in 10 U.S. Lung Transplants Now Due to COVIDAny Change to Menstrual Cycle After COVID Vaccine Is Minor, Temporary: StudiesModerna Begins Testing Booster Shot Aimed at OmicronNewer Rheumatoid Arthritis Drug Might Raise Heart, Cancer RisksScientists Watch, Worry About New 'Stealth' Version of Omicron VariantCommon Gout Drug Is Safe in Patients With Kidney IssuesScientists Discover How the 'Mono' Virus Might Trigger MSSaline IV Drip Just as Good as Pricier Options in Hospital ICUs: StudyCOVID Infection Unlikely From Hospital Surfaces: StudyMany People With Asthma Have Mixed Feelings About Masks: PollMore Proof That COVID Vaccines Won't Harm FertilityMore Than 1 Million U.S. Kids Diagnosed With COVID in Single WeekBiden Administration Withdraws Vaccine Mandate for Large EmployersSurvivors of Severe COVID Face Higher Odds for Another Hospitalization Soon AfterOmicron Batters Already Strained U.S. Hospitals3 Factors Helped Teens Stay Mentally Healthy During PandemicVaccination Key to 'Super Immunity' Against COVID-19Pandemic to Endemic: Is a New Normal Near?Pfizer Begins Testing a COVID Vaccine Targeted to Omicron3 Reasons Why Trying to Get COVID Is a Bad IdeaFree N95 Masks Begin Arriving in U.S. PharmaciesOmicron Shows Signs of Ebbing as U.S. Cases Fall, Hospitalizations Level OffFDA Limits Use of Two COVID Antibody TreatmentsCOVID Can Affect Brains of Hospitalized KidsCOVID Vaccine Hesitancy Falling Faster Among Black Americans Than WhitesEngland to Lift Travel Restrictions for Vaccinated VisitorsAre Pins or a Cast Better for a Broken Wrist?FDA May Limit Use of Two COVID Antibody TreatmentsSome Patients With Macular Degeneration Could Stop Monthly Eye InjectionsYou Don't Have to Smoke to Get Lung CancerCOVID Vaccine Won't Affect Fertility, But Getting COVID MightThree New Studies Confirm Power of Booster Shots Against OmicronHit Your Head? Look for These Warning Signs of ConcussionArthritis & the COVID Vaccine: What You Need to KnowCOVID Boosters Keep Older Americans Out of Hospitals: CDCCOVID Rapid Test Makers Struggling to Meet DemandAHA News: A Healthy Thyroid Can Be Key to a Healthy HeartAnother Study Finds Vaccine Booster 'Neutralizes' Omicron'Artificial Pancreas' Can Help Kids With Type 1 DiabetesGetting Back to Sports After Recovering from COVID-19
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Pfizer Says Omicron-Specific Vaccine Ready by March

HealthDay News
by Robert Preidt and Robin Foster
Updated: Jan 11th 2022

new article illustration

TUESDAY, Jan. 11, 2022 (HealthDay News) -- Pfizer Inc. said Tuesday that a COVID-19 vaccine that specifically targets the Omicron variant will be ready by March.

The company has already started making the new version of the vaccine, Pfizer CEO Albert Bourla told CNBC's "Squawk Box," CBS News reported.

Omicron now accounts for more than 98% of all new COVID-19 cases in the United States, according to the U.S. Centers for Disease Control and Prevention.

Pfizer is also working to improve its current COVID-19 vaccine "to address any future variant of potential concern, if needed," a company spokesperson said in a statement to CBS MoneyWatch.

"In the event that a third dose with the current vaccine is not found to protect against the Omicron variant or other future variants, Pfizer expects to be able to develop and produce a tailor-made vaccine against that variant in approximately 100 days, subject to regulatory approval," the spokesperson added.

Also on Monday, Moderna said in a statement that it's also developing an Omicron-specific vaccine, CBS News reported.

"Given the long-term threat demonstrated by Omicron's immune escape, Moderna will continue to develop an Omicron-specific variant vaccine that it expects to advance into clinical trials in early 2022," the company stated.

In the meantime, booster shots remain the best defense against Omicron, experts said.

In December, White House chief medical adviser Dr. Anthony Fauci predicted that Omicron would become the dominant virus strain in the United States but he has not said that a new Omicron-specific shot is necessary to maintain immunity. Instead, he has urged Americans to get booster shots, which studies have started to show provide the best protection against Omicron.

A recent study from the U.K. Health Security Agency found that booster shots are up to 75% effective at preventing symptomatic COVID-19 infection caused by Omicron.

More information

Visit the U.S. Food and Drug Administration for more on COVID vaccines.

SOURCES: Moderna Inc., news release, Jan. 10, 2022; CBS News




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net